Diagnosis of invasive fungal infections: advances in nonculture systems.
Immunocompromised Host Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
T J
TJ
Walsh
S J
SJ
Chanock
D000935:Antifungal Agents / Q000494:pharmacology; D000946:Antigens, Fungal / Q000097:blood; D001228:Aspergillosis / Q000175:diagnosis / Q000382:microbiology; D002175:Candida / Q000254:growth & development; D002177:Candidiasis / Q000175:diagnosis / Q000382:microbiology; D003047:Coccidioidomycosis / Q000175:diagnosis; D003453:Cryptococcosis / Q000175:diagnosis / Q000382:microbiology; D004271:DNA, Fungal; D016469:Fungemia / Q000175:diagnosis / Q000382:microbiology; D005670:Fusarium; D006660:Histoplasmosis / Q000175:diagnosis; D006801:Humans; D007118:Immunoassay; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000175:diagnosis* / Q000382:microbiology; D016133:Polymerase Chain Reaction; D011541:Pseudallescheria; D014250:Trichosporon; D020096:Zygomycosis / Q000175:diagnosis
D000935:Antifungal Agents; D000946:Antigens, Fungal; D004271:DNA, Fungal